CHELSEA MAY: Open Payments
NPI 1861845638 · LOGAN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 111 payments from 14 companies in 2025. Trend: 2023 $715 · 2024 $1,463 · 2025 $1,766
Food & beverage: $1,753Education: $13
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $592 |
| Janssen Biotech, Inc. | 28 | $430 |
| UCB, Inc. | 23 | $343 |
| Galderma Laboratories, L.P. | 4 | $84 |
| GENZYME CORPORATION | 3 | $60 |
| Lilly USA, LLC | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Incyte Corporation | 2 | $34 |
| LEO Pharma Inc. | 1 | $24 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, NEMLUVIO, DUPIXENT, COSENTYX, Opzelura.
Industry payments across WV — which companies pay providers there.
